BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ding Y, Chen J, Cui G, Wei Y, Lu C, Wang L, Diao H. Pathophysiological role of osteopontin and angiotensin II in atherosclerosis. Biochem Biophys Res Commun 2016;471:5-9. [PMID: 26828266 DOI: 10.1016/j.bbrc.2016.01.142] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Silva GM, França-Falcão MS, Calzerra NTM, Luz MS, Gadelha DDA, Balarini CM, Queiroz TM. Role of Renin-Angiotensin System Components in Atherosclerosis: Focus on Ang-II, ACE2, and Ang-1-7. Front Physiol 2020;11:1067. [PMID: 33013457 DOI: 10.3389/fphys.2020.01067] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
2 Kryzhanovskii SA, Kozhevnikova LM, Tsorin IB, Sukhanova IF, Ionova EO, Stolyaruk VN, Vititnova MB, Miroshkina IA, Seredenin SB. On the Mechanism of the Cardioprotective Action of σ1 Receptor Agonist Anxiolytic Fabomotizole Hydrochloride (Afobazole). Bull Exp Biol Med 2018;165:660-4. [PMID: 30225699 DOI: 10.1007/s10517-018-4236-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
3 da Silva GM, da Silva MC, Nascimento DVG, Lima Silva EM, Gouvêa FFF, de França Lopes LG, Araújo AV, Ferraz Pereira KN, de Queiroz TM. Nitric Oxide as a Central Molecule in Hypertension: Focus on the Vasorelaxant Activity of New Nitric Oxide Donors. Biology (Basel) 2021;10:1041. [PMID: 34681140 DOI: 10.3390/biology10101041] [Reference Citation Analysis]
4 Luo Y, Zhang Q, Ding J, Yu M, Jiang J, Yang F, Wang S, Wang A, Wang L, Wu S, Xia Y, Lu D. Roles of I2PP2A in the downregulation of eNOS Ser1177 phosphorylation by angiotensin II-activated PP2A. Biochem Biophys Res Commun 2019;516:613-8. [PMID: 31239152 DOI: 10.1016/j.bbrc.2019.06.063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Li J, Geng XY, Cong XL. PGC-1α ameliorates AngiotensinII-induced eNOS dysfunction in human aortic endothelial cells. Vascul Pharmacol 2016;83:90-7. [PMID: 27235860 DOI: 10.1016/j.vph.2016.05.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
6 Kaleta B. Osteopontin and Transplantation: Where Are We Now? Arch Immunol Ther Exp (Warsz) 2021;69:15. [PMID: 34019147 DOI: 10.1007/s00005-021-00617-6] [Reference Citation Analysis]
7 Lee GS, Salazar HF, Joseph G, Lok ZSY, Caroti CM, Weiss D, Taylor WR, Lyle AN. Osteopontin isoforms differentially promote arteriogenesis in response to ischemia via macrophage accumulation and survival. Lab Invest 2019;99:331-45. [PMID: 29959420 DOI: 10.1038/s41374-018-0094-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
8 Möbius P, Preidl RHM, Weber M, Amann K, Neukam FW, Wehrhan F. Re-expression of pro-fibrotic, embryonic preserved mediators in irradiated arterial vessels of the head and neck region. Strahlenther Onkol 2017;193:951-60. [DOI: 10.1007/s00066-017-1192-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
9 Zheng Z, Zhao Q, Wei J, Wang B, Wang H, Meng L, Xin Y, Jiang X. Medical prevention and treatment of radiation-induced carotid injury. Biomed Pharmacother 2020;131:110664. [PMID: 32861067 DOI: 10.1016/j.biopha.2020.110664] [Reference Citation Analysis]
10 Bartosińska J, Przepiórka-Kosińska J, Sarecka-Hujar B, Raczkiewicz D, Kowal M, Chyl-Surdacka K, Bartosiński J, Kosiński J, Krasowska D, Chodorowska G. Osteopontin Serum Concentration and Metabolic Syndrome in Male Psoriatic Patients. J Clin Med 2021;10:755. [PMID: 33668559 DOI: 10.3390/jcm10040755] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Li YY, Zhou SH, Chen SS, Zhong J, Wen GB. PRMT2 inhibits the formation of foam cell induced by ox-LDL in RAW 264.7 macrophage involving ABCA1 mediated cholesterol efflux. Biochem Biophys Res Commun 2020;524:77-82. [PMID: 31980179 DOI: 10.1016/j.bbrc.2020.01.040] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhang Y, Tang Y, Yan J. LncRNA-XIST Promotes Proliferation and Migration in ox-LDL Stimulated Vascular Smooth Muscle Cells through miR-539-5p/SPP1 Axis. Oxid Med Cell Longev 2022;2022:9911982. [PMID: 35028010 DOI: 10.1155/2022/9911982] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sakaue T, Suzuki J, Hamaguchi M, Suehiro C, Tanino A, Nagao T, Uetani T, Aono J, Nakaoka H, Kurata M, Sakaue T, Okura T, Yasugi T, Izutani H, Higaki J, Ikeda S. Perivascular Adipose Tissue Angiotensin II Type 1 Receptor Promotes Vascular Inflammation and Aneurysm Formation. Hypertension 2017;70:780-9. [DOI: 10.1161/hypertensionaha.117.09512] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 6.6] [Reference Citation Analysis]
14 Moorman HR, Poschel D, Klement JD, Lu C, Redd PS, Liu K. Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation. Cancers (Basel) 2020;12:E3379. [PMID: 33203146 DOI: 10.3390/cancers12113379] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
15 Hamias R, Rudich A, Greenberg G, Szendro G, Wolak T. Angiotensin 1–7, but not the thrombin-cleaved osteopontin C-terminal fragment, attenuates osteopontin-mediated macrophage-induced endothelial-cell inflammation. Inflamm Res 2018;67:265-75. [DOI: 10.1007/s00011-017-1120-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
16 Yu Q, Zhao J, Liu B. Bazedoxifene activates the angiotensin II-induced HUVEC hypertension model by targeting SIRT1. Exp Ther Med 2022;23:120. [PMID: 34970343 DOI: 10.3892/etm.2021.11043] [Reference Citation Analysis]
17 Ding J, Yu M, Jiang J, Luo Y, Zhang Q, Wang S, Yang F, Wang A, Wang L, Zhuang M, Wu S, Zhang Q, Xia Y, Lu D. Angiotensin II Decreases Endothelial Nitric Oxide Synthase Phosphorylation via AT1R Nox/ROS/PP2A Pathway. Front Physiol 2020;11:566410. [PMID: 33162896 DOI: 10.3389/fphys.2020.566410] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]